ORGO Q2 2017 Earnings — Organogenesis Holdings Inc. Revenue & Financial Results | Market Cap Arena

ORGOOrganogenesis Holdings Inc.

$338M

Q2 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0

Gross Profit

-$221,808

Operating Income

-$221,808

Net Income

$380,334

EPS (Diluted)

$-0.02

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

$175,258

Free Cash Flow

$175,258

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$312M

Total Liabilities

$11M

Stockholders' Equity

$301M

Cash & Equivalents

$286,458

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$221,808	-$500	-44261.6%
Operating Income	-$221,808	-$500	-44261.6%
Net Income	$380,334	-$500	+76166.8%